PEAK1

Chr 15

pseudopodium enriched atypical kinase 1

Also known as: SGK269

This gene encodes a non-receptor tyrosine kinase that is a member of the new kinase family three (NFK3) family. In migrating cells, the encoded protein is associated with the actin cytoskeleton and focal adhesions and promotes developing focal adhesion elongation. This protein may play a role in the regulation of cell migration, proliferation and cancer metastasis. [provided by RefSeq, Mar 2014]

ResearchGenerating clinical summary…

Clinical highlights

Interpreting a novel variant
This gene is strongly intolerant of loss-of-function variation in the population, so LoF variants warrant close attention. No curated mechanism annotation is available — see the mechanism card for the computational prediction and its caveats.Based on population constraint only.
0
Active trials
16
Pubs (1 yr)
—
P/LP submissions
—
P/LP missense
0.44
LOEUF
—
Mechanism
Some data sources returned errors (1)

omim: Error: OMIM fetch failed: 429

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Moderate LoF intolerance
LoF Constraint?
0.44LOEUF
pLI 0.001
Z-score 4.96
OE 0.29 (0.20–0.44)
Moderately constrained

More LoF-intolerant than ~75% of genes

Missense Constraint?
-0.18Z-score
OE missense 1.02 (0.96–1.07)
940 obs / 924.8 exp
Tolerant

Tolerant to missense variation

Observed / Expected Ratios?
LoF OE?0.29 (0.20–0.44)
0≤0.351.4
Missense OE?1.02 (0.96–1.07)
0≤0.61.4
Synonymous OE?0.92
0≤1.21.6
LoF obs/exp: 17 / 57.7Missense obs/exp: 940 / 924.8Syn Z: 1.18

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

PEAK1 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →